Invitation to offer for NHS London Branded Medicines - Tranche A and Annual
Estimated value
£276.5m
Awarded value
—
Suppliers
0
Lots
2
Published
08 Mar 2022
Description
NHS London Branded Medicines - Tranche A <br/><br/>Offer reference number: CM/PHR/20/5614<br/><br/>CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
Scope
- Reference
- CM/PHR/20/5614
- Total value
- £276,524,326 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2022 to 31 Aug 2024
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Submission & procedure
- Submission deadline
- 12 Apr 2022, 12:00 pm
- Submission address
- http://health.atamis.co.uk ↗
- Procedure
- Open procedure
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A | £95.6m | active |
| 2 | CM/PHR/20/5614/02 - NHS Framework for LONDON Branded Medicines - Annual Tranche | £181.0m | active |
Total lots
2
Awarded
0
Estimated total
£276.5m
Awarded total
—
CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A
Start
31 Aug 2022
End
31 Aug 2024
Estimated
£95.6m
CPV
CM/PHR/20/5614/02 - NHS Framework for LONDON Branded Medicines - Annual Tranche
Start
31 Aug 2022
End
31 Aug 2023
Estimated
£181.0m
CPV
Other contracts from The NHS Commissioning Board (operating under the name of NHS England)· 10
Most recent notices published by the same contracting authority.
Other contracts awarded to the same supplier· 0
Cross-buyer view of this supplier's public-sector wins.
No related contracts found.